Trivedi Group

Empowering Human Will. For Cure.

Trivedi Group builds and backs healthcare companies that move care to the patient and evidence to the decision.

30 states

myOnsite Healthcare operates in 30 states.

As of October 2026.

5,104

specimens collected at home in a study with Memorial Sloan Kettering patients, 2022 to 2023.

Bange et al., JNCI Cancer Spectrum, 2024. Results describe this cohort and study period. See the evidence.

35+ years

building healthcare technology, from laboratory software to AI platforms.

The group

Three organizations. One mission.

Explore our featured organizations, or view all six group companies and their current status.

Operating

myOnsite Healthcare

Mobile phlebotomy and specimen collection at homes, offices and events, and in decentralized clinical trials.

Visit myOnsite

Building

MedinovAI

AI-native software for clinical research: trial management, consent, laboratory systems and orchestration.

Visit MedinovAI

Operating

BioDescartes

A biospecimen network that links consent, collection and data for precision research.

Visit BioDescartes

The group also includes Cognaium, Indralok Technologies and JBT Hospitality. See all companies.

Mayank Trivedi at his desk in the myOnsite office
Founder

Products, not labor.

"The only way for India to progress is to make products here, not become a cheap labor supplier to the world, even if it's IT programming work."

Mayank Trivedi, 1995

He founded Sysware Healthcare Systems in 1990, grew Eclipsys India to more than 700 people, and now leads myOnsite Healthcare and MedinovAI.

About Mayank Trivedi

Latest research

Published work on care at home.

2026

Mobile Cancer Screening Integrated with Employer-Sponsored Clinics to Improve Screening Compliance in Working Populations

Panchal H, Trivedi M. IJSMT 2(3), March 2026. doi:10.55041/ijsmt.v2i3.040

2026

Mobile Phlebotomy in MASLD/MASH Clinical Trials: Enhancing Recruitment, Retention, and Data Integrity

Patel Y, Trivedi M. IJSR 15(2), February 2026. doi:10.21275/SR26211102402

All six publications

Talk to the right team the first time.

Talk to us